Berner Industrier AB (STO:BERNER.B)

Checkpoint Therapeutics Revenue

Berner Industrier AB had revenue of 272.82M SEK in the quarter ending June 30, 2025, with 7.09% growth. This brings the company's revenue in the last twelve months to 973.63M, up 2.06% year-over-year. In the year 2024, Berner Industrier AB had annual revenue of 962.66M with 2.11% growth.

• Revenue (ttm): 973.63M
• Revenue Growth: +2.06%
• P/S Ratio: 1.49
• Revenue / Employee: 3.97M
• Employees: 214
• Market Cap: 1.45B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	962.66M	19.90M	2.11%
Dec 31, 2023	942.76M	100.76M	11.97%
Dec 31, 2022	842.00M	98.79M	13.29%
Dec 31, 2021	743.21M	48.04M	6.91%
Dec 31, 2020	695.17M	-9.58M	-1.36%